## **Core Concept**
The question pertains to the management of cervical cancer, specifically focusing on the surgical staging and treatment approach post-radical hysterectomy. Radical hysterectomy is a surgical procedure often performed for early-stage cervical cancer, involving the removal of the uterus, cervix, part of the vagina, and sometimes the ovaries. The FIGO (International Federation of Gynecology and Obstetrics) staging system is commonly used for cervical cancer staging.

## **Why the Correct Answer is Right**
Given that the cancer extends to the lower part of the body of the uterus and the upper part of the cervix, the patient has undergone a radical hysterectomy, which is appropriate for early-stage cervical cancer. The next step in management would typically involve assessing the patient for any adjuvant therapy needs, such as radiation therapy or chemotherapy, based on the final pathology report. This decision is usually guided by factors like lymph node status, margin status, and parametrial involvement. Since the details provided do not specify lymph node involvement or margin status but imply a need for further treatment consideration, the focus shifts to standard practices post-surgery.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Without specific details on why this option is incorrect based on the provided scenario, we cannot directly assess its incorrectness. However, typically, if a patient has undergone a radical hysterectomy for stage Ib cervical cancer with extension as described, additional treatments like radiation or chemotherapy might be considered based on pathological findings.
- **Option B:** Similarly, without specifics, it's hard to directly refute this option. Generally, though, if there's no clear indication for immediate chemotherapy or radiation (e.g., positive margins, lymph node involvement), this might not be the immediate next step.
- **Option C:** This option seems potentially correct in the context of needing further evaluation or treatment post-surgery, such as imaging studies or planning for adjuvant therapy.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that for stage I cervical cancer, radical hysterectomy is a standard treatment option. However, the decision for adjuvant therapy post-surgery is critical and based on pathological risk factors. Patients with stage Ib cervical cancer and involvement of the uterine body might require careful consideration of adjuvant therapy to prevent recurrence.

## **Correct Answer:** C.